Kuhlmann Shirley R. 4
4 · COLLEGIUM PHARMACEUTICAL, INC · Filed Feb 12, 2025
Insider Transaction Report
Form 4
Kuhlmann Shirley R.
EVP and General Counsel
Transactions
- Award
Common Stock
2025-02-10+40,965→ 160,149 total - Award
Common Stock
2025-02-10+29,030→ 189,179 total - Tax Payment
Common Stock
2025-02-10$30.52/sh−9,826$299,890→ 179,353 total - Tax Payment
Common Stock
2025-02-10$30.52/sh−25,149$767,547→ 154,204 total
Footnotes (4)
- [F1]Reflects the grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. One-third (33%) of the RSUs shall vest on February 10, 2026, with the balance of the RSUs vesting in equal annual installments over the following two-year period, subject to the Reporting Person's continued service with the Issuer. The RSUs will be settled on each applicable vesting date in shares of the Issuer's common stock.
- [F2]Effective February 10, 2025, the Compensation Committee of the Board of Directors of the Issuer determined that performance-vesting criteria were met with regard to an aggregate of 29,030 performance share units ("PSUs") granted in the Issuer's three prior fiscal years.
- [F3]Shares withheld by the Issuer to satisfy applicable withholding taxes upon the vesting of PSUs.
- [F4]Shares withheld by the Issuer to satisfy applicable withholding taxes upon the vesting of RSUs.